Literature DB >> 11329139

Differential expression of p16/p21/p27 and cyclin D1/D3, and their relationships to cell proliferation, apoptosis, and tumour progression in invasive ductal carcinoma of the breast.

S C Wong1, J K Chan, K C Lee, W L Hsiao.   

Abstract

In order to understand the intricate relationship of cell proliferation and apoptosis in tumour development, proliferation markers (Ki-67 and c-myc), apoptosis, cell-cycle inducers cyclin D1 and D3, and cell-cycle inhibitors p16(INK4), p21(CIP1), and p27(KIP1) were evaluated in ductal breast carcinoma. The heterogeneous nature of breast tumours provides a system by which the changes in cell-cycle genes can be explored under a wide range of proliferation and apoptotic indices. To address the above issues, immunohistochemical studies were conducted in 40 pairs of tumours and adjacent normal ductal tissues. The TUNEL method was used to identify apoptotic cells. Except for p27/KIP1, the proliferation (Ki-67, c-myc) and the apoptotic indexes together with levels of p16/INK4a, p21/CIP1, cyclin D1, and cyclin D3, were clearly elevated among tumour tissues, while absent in the adjacent normal tissues. Spearman correlation analysis indicated strong associations among apoptotic index, Ki-67, c-myc, and tumour grade. In addition, p21/CIP1 and cyclin D3 were positively correlated, while p16/INK4a, p27/KIP1, and cyclin D1 were negatively correlated with tumour grade. There was clear decoupling between p21 and p27, as well as decoupling between cyclin D1 and cyclin D3, in terms of their relationship to cell proliferation and apoptosis, indicating differential roles in tumour progression. Copyright 2001 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11329139     DOI: 10.1002/path.838

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  35 in total

1.  Hsp22 (HspB8/H11) knockdown induces Sam68 expression and stimulates proliferation of glioblastoma cells.

Authors:  Suhasini Modem; Kannagi Chinnakannu; Uma Bai; G Prem-Veer Reddy; Thipparthi R Reddy
Journal:  J Cell Physiol       Date:  2011-11       Impact factor: 6.384

2.  Combined effect of cyclin D3 expression and abrogation of cyclin D1 prevent mouse skin tumor development.

Authors:  Xian Wang; Christopher Sistrunk; Paula L Miliani de Marval; Yongbaek Kim; Marcelo L Rodriguez-Puebla
Journal:  Cell Cycle       Date:  2012-01-15       Impact factor: 4.534

3.  Co-expression of p16 and p53 characterizes aggressive subtypes of ductal intraepithelial neoplasia.

Authors:  Charles Bechert; Jee-Yeon Kim; Trine Tramm; Fattaneh A Tavassoli
Journal:  Virchows Arch       Date:  2016-09-23       Impact factor: 4.064

4.  Cyclin D3 compensates for the loss of cyclin D1 during ErbB2-induced mammary tumor initiation and progression.

Authors:  Qian Zhang; Kazuhito Sakamoto; Chengbao Liu; Aleata A Triplett; Wan-chi Lin; Hallgeir Rui; Kay-Uwe Wagner
Journal:  Cancer Res       Date:  2011-10-28       Impact factor: 12.701

5.  Magnetic resonance imaging and biological markers in pituitary adenomas with invasion of the cavernous sinus space.

Authors:  Li-Xiong Pan; Zhong-Ping Chen; Yun-Sheng Liu; Ji-Hong Zhao
Journal:  J Neurooncol       Date:  2005-08       Impact factor: 4.130

6.  Oncogenic role of the ubiquitin ligase subunit Skp2 in human breast cancer.

Authors:  Sabina Signoretti; Lucia Di Marcotullio; Andrea Richardson; Sridhar Ramaswamy; Beth Isaac; Montserrat Rue; Franco Monti; Massimo Loda; Michele Pagano
Journal:  J Clin Invest       Date:  2002-09       Impact factor: 14.808

7.  Oridonin induces apoptosis and senescence in colorectal cancer cells by increasing histone hyperacetylation and regulation of p16, p21, p27 and c-myc.

Authors:  Feng-Hou Gao; Xiao-Hui Hu; Wei Li; Hua Liu; Yan-Jie Zhang; Zhu-Ying Guo; Mang-Hua Xu; Shi-Ting Wang; Bin Jiang; Feng Liu; Ying-Zheng Zhao; Yong Fang; Fang-Yuan Chen; Ying-Li Wu
Journal:  BMC Cancer       Date:  2010-11-06       Impact factor: 4.430

8.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Fatma Abdalla; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-09       Impact factor: 4.219

9.  Tuberin and p27 expression in breast cancer patients with or without BRCA germline mutations.

Authors:  Anne Catharina Dressler; Gernot Hudelist; Anneliese Fink-Retter; Daphne Gschwantler-Kaulich; Georg Pfeiler; Margit Rosner; Markus Hengstschläger; Christian F Singer
Journal:  J Cancer Res Clin Oncol       Date:  2013-05-21       Impact factor: 4.553

10.  In vivo effects of rosiglitazone in a human neuroblastoma xenograft.

Authors:  I Cellai; G Petrangolini; M Tortoreto; G Pratesi; P Luciani; C Deledda; S Benvenuti; C Ricordati; S Gelmini; E Ceni; A Galli; M Balzi; P Faraoni; M Serio; A Peri
Journal:  Br J Cancer       Date:  2010-01-12       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.